Cybin Inc.

Status: Publicly traded

Direct answer

Cybin Inc. is publicly traded on AMEX under the ticker CYBN.

Cybin Inc. is a biopharmaceutical firm dedicated to pioneering treatments that leverage psychedelic compounds. Its research and development portfolio encompasses several key candidates: CYB003, a modified psilocybin compound targeting major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine designed to alleviate anxiety conditions; and CYB005, a phenethylamine derivative aimed at combating...

Can you invest in Cybin Inc.?

Yes. Cybin Inc. trades publicly on AMEX as CYBN.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Cybin Inc.

Detailed equity research is provided by MarketSnap.